ADMA Biologics Inc (NASDAQ:ADMA)

8.76
Delayed Data
As of 3:44pm ET
 +0.14 / +1.62%
Today’s Change
7.51
Today|||52-Week Range
14.00
-21.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues1.5M1.4M1.5M1.5M
 
 
 
 
 
Cost of Goods Sold1.7M1.8M2.1M909.6K
 
 
 
 
 
Depreciation And Amortization48.6K54.2K96.8K--
 
 
 
 
 
Operating ExpensesGross Income-261.3K-520.1K-677.2K593.5K
 
 
 
 
 
General Expenses3.3M2.5M3.0M3.8M
 
 
 
 
 
Research And Development1.8M1.5M1.9M1.4M
 
 
 
 
 
Total Operating Expenses5.1M4.4M5.2M4.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.6M-3.0M-3.7M-3.2M
 
 
 
 
 
Extraordinary Credit0.000.000.0067.9K
 
 
Extraordinary Charge-34.8K-14.6K-30.2K--
 
 
 
 
Interest Expense On Debt342.8K335.3K381.3K476.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.0M-3.4M-4.1M-3.6M
 
 
 
 
 
Income Taxes0.000.00-551.7K--
 
 
Net Income-4.0M-3.4M-3.6M-3.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.3M9.3M9.3M9.9M
 
 
 
 
 
Shares To Calculate EPS Diluted9.3M9.3M9.3M9.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.36-$0.38-$0.37
 
 
 
 
 
EPS Diluted-$0.43-$0.36-$0.38-$0.37
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account